Insider · CIK 0001468316
Rosty Raykov
directorotherceoofficer
Files at FENC (FENNEC PHARMACEUTICALS INC.). First filing Nov 9, 2023, latest Sep 1, 2026.
In brief
Rosty Raykov files SEC Form 4 as director and CEO at FENC (FENNEC PHARMACEUTICALS INC.). Since Nov 9, 2023, Rosty Raykov has reported 0 open-market buys worth $0 and 27 open-market sells worth $2.1M, the latest filed on Sep 1, 2026.
A track record needs three past buys with six months of prices behind them; Rosty Raykov has 0, so none is measured yet.
The newest scored trade: sold $121k of FENC on Sep 1, 2026, filed Sep 1, 2026, scored 13 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 11 sells worth $949k.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 27
$0 bought, $2.1M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
FENC: FENNEC PHARMACEUTICALS INC.
FENCOct 12, 2026 · close 10.72
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 13Weak | FENNEC PHARMACEUTICALS INC. | $121k 10,000 shares | -7% | +108% from low-6% from high | |
| 0Weak | FENNEC PHARMACEUTICALS INC. | $96k 10,000 shares | -7% | +66% from low-14% from high | |
| 0Weak | FENNEC PHARMACEUTICALS INC. | $100k 9,599 shares | -6% | +79% from low-6% from high | |
| 0Weak | FENNEC PHARMACEUTICALS INC. | $94k 9,747 shares | -7% | +71% from low-1% from high | |
| 0Weak | FENNEC PHARMACEUTICALS INC. | $70k 10,781 shares | -8% | +13% from low-34% from high | |
| 0Weak | FENNEC PHARMACEUTICALS INC. | $69k 10,946 shares | -9% | +28% from low-35% from high | |
| 0Weak | FENNEC PHARMACEUTICALS INC. | $84k 10,079 shares | -9% | +64% from low-17% from high | |
| 0Weak | FENNEC PHARMACEUTICALS INC. | $80k 10,349 shares | -10% | +56% from low-21% from high | |
| 2Weak | FENNEC PHARMACEUTICALS INC. | $78k 10,312 shares | -10% | +53% from low-22% from high | |
| 8Weak | FENNEC PHARMACEUTICALS INC. | $75k 10,000 shares | -11% | +51% from low-24% from high | |
| 17Weak | FENNEC PHARMACEUTICALS INC. | $81k 10,000 shares | -11% | +107% from low-17% from high | |
| 25Weak | FENNEC PHARMACEUTICALS INC. | $98k 10,000 shares | -11% | +144% from low-1% from high | |
| 9Weak | FENNEC PHARMACEUTICALS INC. | $89k 10,000 shares | -16% | +130% from low-1% from high | |
| 9Weak | FENNEC PHARMACEUTICALS INC. | $81k 10,000 shares | -15% | +105% from low-10% from high | |
| 17Weak | FENNEC PHARMACEUTICALS INC. | $86k 10,000 shares | -14% | +121% from low0% from high | |
| 9Weak | FENNEC PHARMACEUTICALS INC. | $78k 10,000 shares | -13% | +98% from low-5% from high | |
| 30Weak | FENCsell FENNEC PHARMACEUTICALS INC. | $113k 16,667 shares | -19% | +71% from low-3% from high | |
| 8Weak | FENNEC PHARMACEUTICALS INC. | $63k 10,000 shares | -16% | +57% from low-11% from high | |
| 15Weak | FENNEC PHARMACEUTICALS INC. | $53k 10,000 shares | -14% | +32% from low-25% from high | |
| 8Weak | FENNEC PHARMACEUTICALS INC. | $68k 10,000 shares | -13% | - | |
| 16Weak | FENNEC PHARMACEUTICALS INC. | $67k 10,000 shares | -12% | - | |
| 7Weak | FENNEC PHARMACEUTICALS INC. | $61k 10,000 shares | -11% | - | |
| 3Weak | FENNEC PHARMACEUTICALS INC. | $4,808 796 shares | -1% | - | |
| 3Weak | FENNEC PHARMACEUTICALS INC. | $10k 1,635 shares | -2% | - | |
| 0Weak | FENNEC PHARMACEUTICALS INC. | $10k 2,431 shares | -4% | - | |
| 31Weak | FENNEC PHARMACEUTICALS INC. | $42k 3,656 shares | -1% | +79% from low0% from high | |
| 45Moderate | FENNEC PHARMACEUTICALS INC. | $194k 25,044 shares | -8% | +18% from low-26% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 1, 2026 | FENC FENNEC PHARMACEUTICALS INC. | 10,000 0.03% of outstanding | $121k | Sep 1, 2026 | $196k |
| Aug 3, 2026 | FENC FENNEC PHARMACEUTICALS INC. | 10,000 0.03% of outstanding | $96k | Aug 3, 2026 | $194k |
| Jul 1, 2026 | FENC FENNEC PHARMACEUTICALS INC. | 9,599 0.03% of outstanding | $100k | Jul 1, 2026 | $164k |
| Jun 1, 2026 | FENC FENNEC PHARMACEUTICALS INC. | 9,747 0.03% of outstanding | $94k | Jun 1, 2026 | $223k |
| May 1, 2026 | FENC FENNEC PHARMACEUTICALS INC. | 10,781 0.03% of outstanding | $70k | May 1, 2026 | $234k |
| Apr 1, 2026 | FENC FENNEC PHARMACEUTICALS INC. | 10,946 0.03% of outstanding | $69k | Apr 1, 2026 | $243k |
| Mar 2, 2026 | FENC FENNEC PHARMACEUTICALS INC. | 10,079 0.04% of outstanding | $84k | Mar 2, 2026 | $234k |
| Feb 2, 2026 | FENC FENNEC PHARMACEUTICALS INC. | 10,349 0.04% of outstanding | $80k | Feb 2, 2026 | $235k |
| Jan 2, 2026 | FENC FENNEC PHARMACEUTICALS INC. | 10,312 0.04% of outstanding | $78k | Jan 2, 2026 | $254k |
| Dec 5, 2025 | FENC FENNEC PHARMACEUTICALS INC. | 10,000 0.04% of outstanding | $75k | Dec 5, 2025 | $179k |
| Nov 5, 2025 | FENC FENNEC PHARMACEUTICALS INC. | 10,000 0.04% of outstanding | $81k | Nov 5, 2025 | $268k |
| Oct 6, 2025 | FENC FENNEC PHARMACEUTICALS INC. | 10,000 0.04% of outstanding | $98k | Oct 6, 2025 | $170k |
| Sep 4, 2025 | FENC FENNEC PHARMACEUTICALS INC. | 10,000 0.04% of outstanding | $89k | Sep 4, 2025 | $245k |
| Aug 5, 2025 | FENC FENNEC PHARMACEUTICALS INC. | 10,000 0.04% of outstanding | $81k | Aug 5, 2025 | $277k |
| Jul 3, 2025 | FENC FENNEC PHARMACEUTICALS INC. | 10,000 0.04% of outstanding | $86k | Jul 3, 2025 | $306k |
| Jun 5, 2025 | FENC FENNEC PHARMACEUTICALS INC. | 10,000 0.04% of outstanding | $78k | Jun 5, 2025 | $229k |
| May 16, 2025 | FENC FENNEC PHARMACEUTICALS INC. | 16,667 0.06% of outstanding | $100k | May 16, 2025 | $184k |
| May 5, 2025 | FENC FENNEC PHARMACEUTICALS INC. | 10,000 0.04% of outstanding | $63k | May 5, 2025 | $120k |
| Apr 4, 2025 | FENC FENNEC PHARMACEUTICALS INC. | 10,000 0.04% of outstanding | $53k | Apr 4, 2025 | $195k |
| Mar 5, 2025 | FENC FENNEC PHARMACEUTICALS INC. | 10,000 0.04% of outstanding | $68k | Mar 5, 2025 | $127k |
| Feb 5, 2025 | FENC FENNEC PHARMACEUTICALS INC. | 10,000 0.04% of outstanding | $67k | Feb 5, 2025 | $76k |
| Jan 6, 2025 | FENC FENNEC PHARMACEUTICALS INC. | 10,000 0.04% of outstanding | $61k | Jan 6, 2025 | $25k |
| Dec 5, 2024 | FENC FENNEC PHARMACEUTICALS INC. | 796 0.00% of outstanding | $4,808 | Dec 5, 2024 | $33k |
| Dec 3, 2024 | FENC FENNEC PHARMACEUTICALS INC. | 1,635 0.01% of outstanding | $10k | Dec 3, 2024 | $36k |
| Nov 4, 2024 | FENC FENNEC PHARMACEUTICALS INC. | 2,431 0.01% of outstanding | $10k | Nov 4, 2024 | $25k |
Transactions
The newest 50 of 77 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares10b5-1 | +2,778 | $0.00 | $0 | 134,411 | 42 d ago |
| Sep 1, 2026 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common shares10b5-1 | -10,000 | $12.11 | $121k | 124,411 | 42 d ago |
| Aug 3, 2026 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common shares10b5-1 | -10,000 | $9.58 | $96k | 131,633 | Aug 4, 2026 |
| Jul 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +2,778 | $0.00 | $0 | 141,633 | Aug 3, 2026 |
| Jul 1, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares10b5-1 | +2,778 | $0.00 | $0 | 132,857 | Jul 2, 2026 |
| Jul 1, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares10b5-1 | +15,597 | $2.45 | $38k | 148,454 | Jul 2, 2026 |
| Jul 1, 2026 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common shares10b5-1 | -9,599 | $10.41 | $100k | 138,855 | Jul 2, 2026 |
| Jul 1, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Stock Optionsderivative10b5-1 | -15,597 | $2.45 | $38k | 1,525,000 | Jul 2, 2026 |
| May 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares10b5-1 | +2,778 | $0.00 | $0 | 124,229 | Jun 2, 2026 |
| Jun 1, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares10b5-1 | +15,597 | $2.45 | $38k | 139,826 | Jun 2, 2026 |
| Jun 1, 2026 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common shares10b5-1 | -9,747 | $9.62 | $94k | 130,079 | Jun 2, 2026 |
| Jun 1, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Stock Optionsderivative10b5-1 | -15,597 | $2.45 | $38k | 1,556,195 | Jun 2, 2026 |
| Apr 30, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares10b5-1 | +2,778 | $0.00 | $0 | 116,634 | May 1, 2026 |
| May 1, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares10b5-1 | +15,598 | $2.45 | $38k | 132,232 | May 1, 2026 |
| May 1, 2026 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common shares10b5-1 | -10,781 | $6.47 | $70k | 121,451 | May 1, 2026 |
| May 1, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Stock Optionsderivative10b5-1 | -15,598 | $2.45 | $38k | 1,571,792 | May 1, 2026 |
| Mar 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares10b5-1 | +5,208 | $0.00 | $0 | 109,204 | Apr 2, 2026 |
| Apr 1, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares10b5-1 | +15,598 | $2.45 | $38k | 124,802 | Apr 2, 2026 |
| Apr 1, 2026 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common shares10b5-1 | -10,946 | $6.31 | $69k | 113,856 | Apr 2, 2026 |
| Apr 1, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Stock Optionsderivative10b5-1 | -15,598 | $2.45 | $38k | 1,587,390 | Apr 2, 2026 |
| Mar 2, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares10b5-1 | +15,598 | $2.45 | $38k | 114,075 | Mar 3, 2026 |
| Mar 2, 2026 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common shares10b5-1 | -10,079 | $8.36 | $84k | 103,996 | Mar 3, 2026 |
| Feb 28, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares10b5-1 | +5,208 | $0.00 | $0 | 109,204 | Mar 3, 2026 |
| Mar 2, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Stock Optionsderivative10b5-1 | -15,598 | $2.45 | $38k | 1,587,390 | Mar 3, 2026 |
| Feb 2, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares10b5-1 | +15,598 | $2.45 | $38k | 108,826 | Feb 2, 2026 |
| Jan 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +5,208 | $0.00 | $0 | 93,228 | Feb 2, 2026 |
| Feb 2, 2026 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common shares10b5-1 | -10,349 | $7.76 | $80k | 98,477 | Feb 2, 2026 |
| Feb 2, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Stock Optionsderivative10b5-1 | -15,598 | $2.45 | $38k | 1,602,988 | Feb 2, 2026 |
| Dec 31, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares10b5-1 | +5,208 | $0.00 | $0 | 82,734 | Jan 5, 2026 |
| Jan 2, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares10b5-1 | +15,598 | $2.45 | $38k | 98,332 | Jan 5, 2026 |
| Jan 2, 2026 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common shares10b5-1 | -10,312 | $7.60 | $78k | 88,020 | Jan 5, 2026 |
| Jan 2, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Stock Optionsderivative10b5-1 | -15,598 | $2.45 | $38k | 1,618,586 | Jan 5, 2026 |
| Dec 5, 2025 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common shares10b5-1 | -10,000 | $7.54 | $75k | 77,526 | Dec 5, 2025 |
| Dec 1, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +5,208 | $0.00 | $0 | 87,526 | Dec 2, 2025 |
| Nov 5, 2025 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common shares10b5-1 | -10,000 | $8.10 | $81k | 82,318 | Nov 6, 2025 |
| Oct 31, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +5,208 | $0.00 | $0 | 92,318 | Nov 3, 2025 |
| Oct 8, 2025 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares | +4,609 | $2.45 | $11k | 87,110 | Oct 8, 2025 |
| Oct 8, 2025 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Stock Optionsderivative | -4,609 | $2.45 | $11k | 1,634,184 | Oct 8, 2025 |
| Oct 6, 2025 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common shares10b5-1 | -10,000 | $9.78 | $98k | 82,501 | Oct 6, 2025 |
| Sep 30, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +5,208 | $0.00 | $0 | 92,501 | Oct 1, 2025 |
| Sep 5, 2025 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares | +36,207 | $2.45 | $89k | 87,293 | Sep 8, 2025 |
| Sep 5, 2025 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Stock Optionsderivative | -36,207 | $2.45 | $89k | 1,638,793 | Sep 8, 2025 |
| Sep 4, 2025 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common shares10b5-1 | -10,000 | $8.92 | $89k | 51,086 | Sep 4, 2025 |
| Aug 31, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +5,208 | $0.00 | $0 | 61,086 | Sep 2, 2025 |
| Aug 5, 2025 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common shares10b5-1 | -10,000 | $8.09 | $81k | 55,878 | Aug 5, 2025 |
| Jul 31, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +5,208 | $0.00 | $0 | 65,878 | Aug 1, 2025 |
| Jul 3, 2025 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common shares10b5-1 | -10,000 | $8.61 | $86k | 60,670 | Jul 7, 2025 |
| Jun 30, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +5,208 | $0.00 | $0 | 70,670 | Jul 1, 2025 |
| Jun 5, 2025 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common shares10b5-1 | -10,000 | $7.78 | $78k | 65,462 | Jun 6, 2025 |
| May 31, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +5,208 | $0.00 | $0 | 75,462 | Jun 2, 2025 |
50 of 77 rows shown.
Questions about Rosty Raykov
Answered from the filings on this page, as of the latest one.
Is Rosty Raykov buying or selling?
In the last 12 months Rosty Raykov reported 0 open-market buys worth $0 and 11 open-market sells worth $949k on SEC Form 4; the latest was sold $121k of FENC on Sep 1, 2026. Grants, option exercises and tax withholding are not counted.
How did Rosty Raykov's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Rosty Raykov has 0.
Where does Rosty Raykov file Form 4?
Rosty Raykov has filed Form 4 at FENC (FENNEC PHARMACEUTICALS INC.) as CHIEF EXECUTIVE OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.